RAS GTPase inhibitor 1

CAS No. 2252242-32-1

RAS GTPase inhibitor 1( —— )

Catalog No. M33100 CAS No. 2252242-32-1

RAS GTPase inhibitor 1 is a RAS GTPase inhibitor with potential antitumor activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 567 Get Quote
5MG 848 Get Quote
10MG 1159 Get Quote
25MG 1674 Get Quote
50MG 2190 Get Quote
100MG 2790 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    RAS GTPase inhibitor 1
  • Note
    Research use only, not for human use.
  • Brief Description
    RAS GTPase inhibitor 1 is a RAS GTPase inhibitor with potential antitumor activity.
  • Description
    RAS GTPase inhibitor 1 (example 51) is a RAS GTPase inhibitor with anti-tumor activity, extracted from patent WO2018212774A1. RAS GTPase inhibitor 1 (example 51) exhibits an EC50 less than 1 μM for at least one nucleotide exchange and an IC50 less than 1 μM in H727 cells.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    Raf
  • Recptor
    Raf
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2252242-32-1
  • Formula Weight
    565.99
  • Molecular Formula
    C27H28ClF4N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(C(O)=O)(F)(F)F.N([C@H](CC)C1CC1)C=2C3=C(C(=CC=C3)C=4CCNCC4)N=C(NC5=CC(Cl)=C(F)C=C5)N2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. WATERSON, Alex G, et al. QUINAZOLINE COMPOUNDS AS MODULATORS OF RAS SIGNALING. Patent. WO2018212774A1.
molnova catalog
related products
  • PLX-7904

    A potent and selective BRaf inhibitor with IC50 of 5 nM against BRaf V600E in mutant RAS expressing cells.

  • GDC-0879

    A potent and selective B-Raf kinase inhibitor with IC50 of 0.13 nM against purified B-Raf V600E and a cellular pERK IC50 of 63 nM in the MALME-3M cell line.

  • Uplarafenib

    Uplarafenib (B-Raf IN 10) is a potent BRAF inhibitor with an IC50 of 50-100 nM. B-Raf IN 10 exhibits antitumor activity that may influence cell proliferation and differentiation, making it suitable for studying solid tumors.